I. Luescher

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (6) Recensions (1)

Co-auteur

Date

Source

Mot-clé

cancer (6) Cancer (6) Cancer (6) T cells (5) Vaccines (4) Patients (4) Human beings (4) Cells (4) Patients (4) Vaccination (3) Peptides (3) Ligands (3) Vaccination (3) technologie (2) Development (2) Technology (2) Plates (Engineering) (2) Motion (2) Melanoma (2) Mechanics, Analytic (2) Impact (2) Dynamics (2) Cellular immunity (2) Cancer--Patients (2) Blood (2) Antigens (2) Receptors (2) Use (2) Technology (2) puits (1)

Documents écrit par I. Luescher (6) | parle de I. Luescher (0)

CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
P. Baumgaertner et al. (10 août 2022)
Vaccination with LAG-3Ig (IMP321) and peptides induces specific CD4 and CD8 T-cell responses in metastatic melanoma patients - report of a phase I/IIa clinical trial.
A. Legat et al. (2016)
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
M. Hebeisen et al. (2015)
Analysis, Isolation, and Activation of Antigen-Specific CD4 + and CD8+ T Cells by Soluble MHC-Peptide Complexes
J. Schmidt et al. (2013)
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.
T. Lövgren et al. (2012)
NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.
N. Redjimi et al. (2011)